LivaNova Completes Sale of Cardiac Rhythm Management Business to MicroPort Scientific Corporation

April 30, 2018 by Website Admin in

LivaNova today announced it has successfully completed the divestiture of its Cardiac Rhythm Management business to MicroPort Scientific Corporation for $190 million in cash.

Tweet

Share

Pin it

Previous StoryLivaNova Announces One-Millionth Inspire Adult Oxygenator Patient Next StoryMoleculin Announces Engagement with Voisin Consulting Life Sciences to Expand Annamycin Clinical Trial